Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Mar. 31, 2019	Mar. 31, 2018
REVENUES:
License and contract	$ 0	$ 8,962,709	$ 34,505	$ 46,516,370
OPERATING EXPENSES:
Research and development	3,943,982	7,068,849	10,528,329	27,277,830
General and administrative	1,818,796	2,411,302	5,947,943	5,581,066
Total operating expenses	5,762,778	9,480,151	16,476,272	32,858,896
(Loss) income from operations	(5,762,778)	(517,442)	(16,441,767)	13,657,474
OTHER INCOME (EXPENSE):
Investment income	107,460	86,496	361,212	219,578
Interest expense	(71,812)	(326,983)	(370,981)	(1,175,023)
Total other income (expense), net	35,648	(240,487)	(9,769)	(955,445)
(Loss) income before income taxes	(5,727,130)	(757,929)	(16,451,536)	12,702,029
Income tax benefit	0	18,746	0	192,611
NET (LOSS) INCOME	$ (5,727,130)	$ (739,183)	$ (16,451,536)	$ 12,894,640
Basic net (loss) income per common share	$ (0.03)	$ (0.00)	$ (0.08)	$ 0.07
Diluted net (loss) income per common share	$ (0.03)	$ (0.00)	$ (0.08)	$ 0.06
Weighted average number of common shares outstanding used in computing basic net income (loss) per common share	207,016,304	197,485,758	206,148,695	197,277,286
Weighted average number of common shares outstanding used in computing diluted net income (loss) per common share	207,016,304	197,485,758	206,148,695	202,712,963